Once-monthly oral ibandronate is at least as effective as daily oral ibandronate in postmenopausal osteoporosis: 2-year findings from MOBILE.

被引：0
|
作者：
McClung, MR
Drezner, MK
Reginster, JY
Bolognese, M
Hughes, C
Mairon, N
Bonvoisin, B
Delmas, PD
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR USA
[2] Univ Wisconsin, Madison, WI 53706 USA
[3] Univ Liege, B-4000 Liege, Belgium
[4] Bethesda Hlth Res, Bethesda, MD USA
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Univ Lyon 1, F-69365 Lyon, France
[7] INSERM, Res Unit 403, F-69008 Lyon, France
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 50 条
  • [41] Once-monthly ibandronate for postmenopausal osteoporosis: Review of a new dosing regimen
    Pyon, Eunice Y.
    CLINICAL THERAPEUTICS, 2006, 28 (04) : 475 - 490
  • [42] Intravenous ibandronate injections are at least as effective and similarly well tolerated as daily oral ibandronate in postmenopausal osteoporosis: 1-year results from DIVA
    Adami, S
    Nuti, R
    Czerwinski, E
    Hughes, C
    Ward, P
    Bonvoisin, B
    Tanko, LB
    BONE, 2005, 36 : S137 - S138
  • [43] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [44] Rapid suppression of serum CTX with once-monthly oral ibandronate
    Adami, S.
    Boisdron, J.
    Silverman, S.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S211 - S211
  • [45] ONCE-MONTHLY ORAL IBANDRONATE A NEW BISPHOSPHONATE DOSING CONCEPT
    Reginster, J.
    Miller, P.
    Delmas, P.
    Lorenc, R.
    Stakkestad, J.
    Christiansen, C.
    Wiese, C.
    Wilson, K.
    Coutant, K.
    Bonvoisin, B.
    Dumont, E.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S85 - S85
  • [46] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [47] A novel bisphosphonate dosing regimen: Once-monthly oral ibandronate
    Cooper, C
    Adami, S
    Stepan, JJ
    Wiese, C
    Wilson, K
    Coutant, K
    Dumont, E
    Reginster, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 452 - 453
  • [48] Once-monthly ibandronate dosing is more effective than daily dosing for improving bone mineral density: Mobile 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S160 - S161
  • [49] Efficacy and Tolerability of Once-Monthly Oral Ibandronate (150 mg) and Once-Weekly Oral Alendronate (70 mg): Additional Results From the Monthly Oral Therapy With Ibandronate for Osteoporosis Intervention (MOTION) Study
    Emkey, Ronald
    Delmas, Pierre D.
    Bolognese, Michael
    Borges, Lindolfo C.
    Cosman, Felicia
    Ragi-Eis, Sergio
    Recknor, Christopher
    Zerbini, Cristiano A.
    Neate, Colin
    Sedarati, Farhad
    Epstein, Solomon
    CLINICAL THERAPEUTICS, 2009, 31 (04) : 751 - 761
  • [50] Monthly oral ibandronate is effective and safe therapy for women with postmenopausal osteoporosis: Mobile 1-year results.
    Epstein, S
    Bolognese, MA
    Miller, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S196 - S196
12345